Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of colon cancer because it has been recurred and produced few side effects in patients. Secretory glycoprotein 90K has been found at elevated level in various cancer tissues and sera. We investigated to establish a more effective DC vaccine for the treatment of colon cancer in which the levels of 90K are elevated. Methods: We obtained the concentrated 90K from 293T cells stably expressing 90K. DCs were cultured from peripheral blood monocytes, and a DC vaccine pulsed with tumor lysate was compared with a DC vaccine pulsed with 90K. We measured the functional activity for CTLs by using IFN-γ-enzyme linked immunoabsorbent spot (ELISPOT) assay. Results: DCs pulsed with tumor lysate＋90K exhibited the enhanced T cell stimulation, polarization of naïve T cell toward Th1. The CTLs generated by DCs pulsed with 90K efficiently lysed HCT116 cells. The results indicate that 90K-speicifc-CTLs can recognize 90K proteins naturally presented by colon cancer cells. Conclusion: Our study suggests that 90K-specific CTLs generated by 90K-pulsed DCs could be useful effector cells for immunotherapy in colon cancer.
Abstract
Background: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of colon cancer because it has been recurred and produced few side effects in patients. Secretory glycoprotein 90K has been found at elevated level in various cancer tissues and sera. We investigated to establish a more effective DC vaccine for the treatment of colon cancer in which the levels of 90K are elevated. Methods: We obtained the concentrated 90K from 293T cells stably expressing 90K. DCs were cultured from peripheral blood monocytes, and a DC vaccine pulsed with tumor lysate was compared with a DC vaccine pulsed with 90K. We measured the functional activity for CTLs by using IFN-γ-enzyme linked immunoabsorbent spot (ELISPOT) assay. Results: DCs pulsed with tumor lysate＋90K exhibited the enhanced T cell stimulation, polarization of naïve T cell toward Th1. The CTLs generated by DCs pulsed with 90K efficiently lysed HCT116 cells. The results indicate that 90K-speicifc-CTLs can recognize 90K proteins naturally presented by colon cancer cells. Conclusion: Our study suggests that 90K-specific CTLs generated by 90K-pulsed DCs could be useful effector cells for immunotherapy in colon cancer.
참고문헌 (17)
- Banchereau J, "Dendritic cells and the control of immunity", Nature, 392, pp.245~252 (1998)
- Banchereau J, "Immunobiology of dendritic cells", Annu Rev Immunol, 18, pp.767~811 (2000)
- Steinman RM, "Active immunization against cancer with dendritic cells: the near future", Int J Cancer, 94, pp.459~473 (2001)
- Zitvogel L, "Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines", J Exp Med, 183, pp.87~97 (1996)
- Kaplan JM, "Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens", J Immunol, 163, pp.699~707 (1999)
- Iacobelli S, "Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast canc", Cancer Res, 46, pp.3005~3010 (1986)
- Rosenberg I, "Mac-2- binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin", J Biol Chem, 266, pp.18731~18736 (1991)
- Koths K, "Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain", J Biol Chem, 268, pp.14245~14249 (1993)
- Ullrich A, "The secreted tumor-associated antigen 90K is a potent immune stimulator", J Biol Chem, 269, pp.18401~18407 (1994)
- Iacovazzi PA, "Serum 90K", MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein, 2001, pp.39, 961~965
- Fusco O, "90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells", Int J Cancer, 79, pp.23~26 (1998)
- Park YP, "Up-regulation of Mac-2 binding protein by hTERT in gastric cancer", Int J Cancer, 120, pp.813~820 (2007)
- Ozaki Y, "Expression and immunogenicity of a tumor-associated antigen, 90K", Mac-2 binding protein, in lung carcinoma, 2002, pp.95, 1954~1962
- Becker R, "Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP", 90K, 2008, pp.22, 3059~3067
- Mayordomo JI, "Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity", Nat Med, 1, pp.1297~1302 (1995)
- Porgador A, "Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes", J Exp Med, 182, pp.255~260 (1995)
- Boczkowski D, "Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo", J Exp Med, 184, pp.465~472 (1996)